Arista beats Q1 estimates with strong AI demand but holds 2025 guidance amid tariff uncertainty. Analysts cut Arista price targets despite solid Q1 results, citing cautious full-year outlook. Feel unsure about the market's next move?

Shares of commercial-stage biotech Geron ( NASDAQ: GERN ) couldn't quite surmount the hump of Hump Day. After the company released its latest set of quarterly figures, its stock price wobbled as investors determined how best to digest the results.

Quarterly Net Operating Revenues of $487.3 million, up ...

Vero Beach, Fla., May 07, 2025 ( GLOBE NEWSWIRE ) -- Orchid Island Capital, Inc. ( the "Company" ) ( NYSE: ORC ) announced today that the Board of Directors of the Company declared a monthly cash dividend for the month of May 2025. The dividend of $0.12 per share will be paid June 27, 2025 to ...

Vero Beach, Fla., May 07, 2025 ( GLOBE NEWSWIRE ) -- Orchid Island Capital, Inc. ( the "Company" ) ORC announced today that the Board of Directors of the Company declared a monthly cash dividend for the month of May 2025.

The movie theater company beat analyst estimates for revenue and earnings per share in the quarter. Don't miss this list of 10 overlooked stocks-including one paying a 9% dividend-before Wall Street catches on. Movie theater company AMC Entertainment Holdings AMC reported first-quarter financial ...

Opendoor reports first-quarter earnings on Tuesday after the market closed. The company reports sales of $1.15 billion, beating the consensus estimate of $1.06 billion Get prepared for the Fed's next move-live with Matt Maley on Wednesday, May 7 at 6 PM ET. Reserve your free spot now.

Rocky Mountain High RMHB shares closed up 52.00% at $0.00 Target Group CBDY shares closed up 35.29% at $0.00 4Front Ventures FFNTF shares closed up 16.67% at $0.00 Blueberries Medical BBRRF shares closed up 13.00% at $0.01 1933 Industries TGIFF shares closed up 9.09% at $0.01

Deep Track's Misleading Investor Presentation Demonstrates its Single-Minded Approach to Abandon Long-Term Value Opportunities in Exchange for Short-Term Return Urges Stockholders to Vote "FOR" All Four Dynavax Director Nominees on the GOLD Proxy Card Today

REYKJAVIK, Iceland, May 7, 2025 - Alvotech ( NASDAQ: ALVO, or the "Company" ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported financial results for the first quarter of 2025 and provided a summary of recent ...